A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

Clinical trial NCT06280157 · TERMINATED

Trial details

NCT number: NCT06280157
Sponsor: Minervax ApS
Status: TERMINATED
Study type: OBSERVATIONAL

Group B Streptococcus Infection

Start date: 2024-01-18
Primary completion: 2025-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.